Search Orphan Drug Designations and Approvals
-
Generic Name: | cadazolid |
---|---|
Date Designated: | 08/08/2017 |
Orphan Designation: | Treatment of clostridium difficile infection in pediatric patients |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
Date Designation Withdrawn or Revoked: | 05/14/2021 |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Actelion Pharmaceuticals Ltd 16 Gewerbestrasse Allschwil, Basel-Landschaft Switzerland The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-